News & Events about Dermtech Inc.
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the grant to four new employees of restricted stock units representing the contingent right to receive up to an aggregate of 44,669 shares of...
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced favorable coverage policies from two commercial payers comprising a Blues plan in Hawaii and a physician-founded, member-focused and...
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the Defense Health Agencys Lab Joint Working Group has recommended the Companys foundational assay included in the DermTech Melanoma Test...
Ticker Report
9 months ago
Landscape Capital Management L.L.C. raised its holdings in shares of DermTech, Inc. (NASDAQ:DMTK Get Rating) by 187.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 176,226 shares of the companys stock after purchasing an additional 115,023 shares during the quarter...
Business Wire
11 months ago
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that SKIN: The Journal of Cutaneous Medicine has published its original research study, with Daniel M. Siegel, MD, MS as the lead author. A...